Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization

Langenbeck's Archives of Surgery

Volumn 400, Issue 2, 2015, Pages 237-246

  Malinowski, Maciej ^a   Stary, Victoria ^a   Lock, Johan F ^a   Schulz, Antje ^a   Jara, Maximilian ^a   Seehofer, Daniel ^a   Gebauer, Bernhard ^a   Denecke, Timm ^a   Geisel, Dominik ^a   Neuhaus, Peter ^a   Stockmann, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Extended hepatectomy; Future liver remnant; Portal vein embolization

Indexed keywords

ANTIBIOTIC AGENT; HEPARIN; POLYVINYL ALCOHOL;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILOMA; CHOLANGITIS; CHOLESTASIS; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; EMBOLISM; FEMALE; FEVER; FUTURE LIVER REMNANT; GOUT; HERPES ZOSTER; HUMAN; INFECTION; INFLAMMATION; LIVER DISEASE; LIVER FUNCTION; LIVER HYPERTROPHY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN THROMBOSIS; NAUSEA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERITONITIS; PORTAL VEIN; PORTAL VEIN EMBOLIZATION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK; VOLUMETRY; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; FACTUAL DATABASE; FOLLOW UP; HYPERTROPHY; LIVER NEOPLASMS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; ORGAN SIZE; PATHOLOGY; PREOPERATIVE CARE; PROCEDURES; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; HYPERTROPHY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; ORGAN SIZE; PORTAL VEIN; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84925536065     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-014-1266-7     Document Type: Article

References (40)

1. Neuhaus P, Thelen A (2008) Radical surgery for right-sided Klatskin tumor. HPB (Oxford) 10(3):171–173. doi:10.1080/13651820801992708
2. Arnold D, Rummeny EJ, Kirchner T, Ridwelski K, Oettle H, Hartmann JT, Moehler M, Holscher A, Lang H, Schlitt HJ, Neuhaus P (2009) Diagnosis and treatment of liver metastases from primary colorectal tumour]. Onkologie 32(Suppl 2):7–12
3. Lim KC, Chow PK, Allen JC, Siddiqui FJ, Chan ES, Tan SB (2012) Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 99(12):1622–1629
4. Helling TS (2006) Liver failure following partial hepatectomy. HPB (Oxford) 8(3):165–174
5. van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malago M, Jalan R, Saner FH (2008) Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28(6):767–780
6. Garcea G, Maddern GJ (2009) Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg 16(2):145–155
7. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204(5):854–862. doi:10.1016/j.jamcollsurg.2006.12.032, discussion 862–854
8. de Meijer VE, Kalish BT, Puder M, Ijzermans JN (2010) Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 97(9):1331–1339
9. McCall J, Koea J, Gunn K, Rodgers M, Jarvis J (2001) Liver resections in Auckland 1998–2001: mortality, morbidity and blood product use. N Z Med J 114(1144):516–519
10. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57. doi:10.1097/SLA.0b013e31815f6e5b
11. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10(5):803–808
12. de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98(6):825–834. doi:10.1002/bjs.7456
13. Nishiyama Y, Yamamoto Y, Hino I, Satoh K, Wakabayashi H, Ohkawa M (2003) 99mTc galactosyl human serum albumin liver dynamic SPET for pre-operative assessment of hepatectomy in relation to percutaneous transhepatic portal embolization. Nucl Med Commun 24(7):809–817. doi:10.1097/01.mnm.0000080247.50447.34
14. Hirai I, Kimura W, Fuse A, Suto K, Urayama M (2003) Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 133(5):495–506. doi:10.1067/msy.2003.138
15. Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M, Lehmann S, Niehues SM, Schwabe M, Lemke AJ, Neuhaus P (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 250(1):119–125. doi:10.1097/SLA.0b013e3181ad85b5
16. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, Sugimachi K (1999) Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 188(3):304–309
17. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN (2002) Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137(6):675–680, discussion 680–671
18. Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R (1993) Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 17(1):109–115
19. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN (2013) Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 20(8):2493–2500
20. de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, Auperin A, Goere D, Elias D, Hechelhammer L (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17(8):2081–2089
21. Nanashima A, Sumida Y, Shibasaki S, Takeshita H, Hidaka S, Sawai T, Shindou H, Abo T, Yasutake T, Nagayasu T, Sakamoto I (2006) Parameters associated with changes in liver volume in patients undergoing portal vein embolization. J Surg Res 133(2):95–101
22. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA (2006) Platelet-derived serotonin mediates liver regeneration. Science 312(5770):104–107
23. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
24. Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12(2):139–146. doi:10.1111/j.1477-2574.2009.00151.x
25. Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR (2008) Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg 143(3):247–253, discussion 253
26. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812
27. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, Makuuchi M, Kawasaki S (1999) Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29(4):1099–1105
28. Denys A, Lacombe C, Schneider F, Madoff DC, Doenz F, Qanadli SD, Halkic N, Sauvanet A, Vilgrain V, Schnyder P (2005) Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol: JVIR 16(12):1667–1674. doi:10.1097/01.RVI.0000182183.28547.DC
29. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94(11):1386–1394. doi:10.1002/bjs.5836
30. Hoekstra LT, van Lienden KP, Doets A, Busch OR, Gouma DJ, van Gulik TM (2012) Tumor progression after preoperative portal vein embolization. Ann Surg 256(5):812–817, discussion 817–818
31. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M (1996) Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200(2):559–563
32. Hori T, Yagi S, Iida T, Taniguchi K, Yamagiwa K, Yamamoto C, Hasegawa T, Yamakado K, Kato T, Saito K, Wang L, Torii M, Hori Y, Takeda K, Maruyama K, Uemoto S (2007) Stability of cirrhotic systemic hemodynamics ensures sufficient splanchnic blood flow after living-donor liver transplantation in adult recipients with liver cirrhosis. World J Gastroenterol 13(44):5918–5925
33. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA Jr, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN (2005) Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol JVIR 16(2 Pt 1):215–225. doi:10.1097/01.RVI.0000147067.79223.85
34. Yoo H, Ko GY, Gwon DI, Kim JH, Yoon HK, Sung KB, Kim N, Lee J (2009) Preoperative portal vein embolization using an Amplatzer vascular plug. Eur Radiol 19(5):1054–1061. doi:10.1007/s00330-008-1240-2
35. Geisel D, Malinowski M, Powerski MJ, Wustefeld J, Heller V, Denecke T, Stockmann M, Gebauer B (2013) Improved hypertrophy of future remnant liver after portal vein embolization with plugs, coils and particles. Cardiovasc Intervent Radiol. doi:10.1007/s00270-013-0810-0
36. Kusaka K, Imamura H, Tomiya T, Makuuchi M (2004) Factors affecting liver regeneration after right portal vein embolization. Hepatogastroenterology 51(56):532–535
37. de Baere T, Denys A, Paradis V (2009) Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol 19(6):1435–1442. doi:10.1007/s00330-008-1277-2
38. Owen RJ, Mercer JR, Al-Saif F, Molinari M, Ashforth RA, Rajotte RV, Conner-Spady B, Shapiro AM (2009) Portal vein embolization with radiolabeled polyvinyl alcohol particles in a swine model: hepatic distribution and implications for pancreatic islet cell transplantation. Cardiovasc Intervent Radiol 32(3):499–507. doi:10.1007/s00270-009-9544-4
39. Vollmar B, Menger MD (2009) The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89(4):1269–1339. doi:10.1152/physrev.00027.2008
40. Denys AL, Abehsera M, Leloutre B, Sauvanet A, Vilgrain V, O’Toole D, Belghiti J, Menu Y (2000) Intrahepatic hemodynamic changes following portal vein embolization: a prospective Doppler study. Eur Radiol 10(11):1703–1707